Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block unsafe drugs from non-compliant manufacturers. With the 2025 GLP-1 crackdown, thousands of shipments have been detained, reshaping global pharma supply chains and forcing manufacturers to meet strict U.S. quality standards.